Big tech could reshape healthcare faster than regulators expect, warns MEP
The European Parliament's health committee chair says AI and biofoundries could fundamentally change drug development, forcing Europe to rethink pharmaceutical policy ...
Record details
Published: 14 August 2026
Source: Euractiv Digital
Category: News
Topics: Regulation · Healthcare · Biotech
Retrieved: 15 August 2026
Related evidence
These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.
Open Joint Letter on the AI Act Regulating AI-embedded Medical Devices
Center for Democracy & Technology · 16 July 2026
Navigating the Global Regulatory Landscape for Exosome-Based Therapeutics: Challenges, Strategies, and Future Directions
OpenAlex · 30 July 2025
Bipartisan Lawmakers Are Fighting HHS’ 340B Rebate Push
Above the Law (legal tech) · 11 August 2026
India’s drug regulator has not adopted AI for regulatory approvals: Govt
MediaNama (IN) · 6 August 2026
Biotech giant Amgen says patient data stolen from third-party cloud systems
The Record (Recorded Future News) · 3 August 2026
Closing the data loop in AI-driven drug discovery
MIT Technology Review · 27 July 2026
How to cite this record
ethics.ai (14 August 2026), “Big tech could reshape healthcare faster than regulators expect, warns MEP,” evidence record 19685, https://ethics.ai/record/19685 (originally published by Euractiv Digital).
Use and limitations
This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.